These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow. Bagni B, Portaluppi F, Montanari L, Prandini N, Zatta G. J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211 [Abstract] [Full Text] [Related]
3. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function]. Di Lorenzo I, Stiglich F, Barbonetti C, Bonomo F, Maspero S, Paini S, Bottinelli G. Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030 [Abstract] [Full Text] [Related]
5. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH. Kanazawa T, Shimizu M, Seto H, Kageyama M, Kameda K, Toyoshima S, Tomizawa G, Watanabe N, Inagaki S. Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597 [Abstract] [Full Text] [Related]
7. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. Taylor A, Eshima D, Fritzberg AR, Christian PE, Kasina S. J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350 [Abstract] [Full Text] [Related]
8. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine. Taylor A, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD. Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734 [Abstract] [Full Text] [Related]
10. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method]. Hashimoto T, Matsumoto K, Ishibashi R, Iwasaki R, Sanmiya T, Hashimoto J, Kunieda E, Nakamura K, Kubo A. Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099 [Abstract] [Full Text] [Related]
11. 99Tcm-MAG3 for quantitation of differential renal function. Llamas-Elvira JM, Martinez-Paredes M, Jimenez-Heffernan A, Sopena R, Requena MJ, Gonzalez FM, Torres M, Mateo A. Nucl Med Commun; 1989 Oct; 10(10):759-64. PubMed ID: 2559380 [Abstract] [Full Text] [Related]
12. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)]. Ha-Kawa SK, Suga Y, Satou H, Tanaka Y. Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073 [Abstract] [Full Text] [Related]
13. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. Jafri RA, Britton KE, Nimmon CC, Solanki K, Al-Nahhas A, Bomanji J, Fettich J, Hawkins LA. J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516 [Abstract] [Full Text] [Related]
15. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent. Eshima D, Taylor A. Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184 [Abstract] [Full Text] [Related]
16. [Evaluation of renal function using 99mTc-MAG3: comparison with 123I-OIH and 99mTc-DTPA]. Takayama T, Aburano T, Shuke N, Yokoyama K, Michigishi T, Sun BF, Tonami N, Hisada K, Takabatake T, Ohta H. Kaku Igaku; 1993 Jul; 30(7):753-60. PubMed ID: 8377298 [Abstract] [Full Text] [Related]
18. Prediction of renal transplant survival from early postoperative radioisotope studies. Russell CD, Yang H, Gaston RS, Hudson SL, Diethelm AG, Dubovsky EV. J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523 [Abstract] [Full Text] [Related]
19. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney. Trejtnar F, Laznicek M, Laznickova A. Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542 [Abstract] [Full Text] [Related]
20. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)]. Shirakawa S, Tamaki N, Torizuka T, Fujita T, Yano S, Tsuchimochi S, Yonekura Y, Konishi J, Terai A. Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]